img

Global Paclitaxel Drug Market Research Report 2024


Published on: 2024-01-04 | No of Pages : 98 | Industry : Pharma & Healthcare

Publisher : Q | Format : PDF

Global Paclitaxel Drug Market Research Report 2024

The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
30mg
100mg


Segment by Application


Hospital
Drugs Store

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE




By Company


Luye Pharma
CSPC Company
Celgene
Jiangsu Hengrui
Bristol-Myers Squibb
Pfizer
Teva
Mylan
Novartis

Table of Content

1 Paclitaxel Drug Market Overview
1.1 Product Overview and Scope of Paclitaxel Drug
1.2 Paclitaxel Drug Segment by Type
1.2.1 Global Paclitaxel Drug Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 30mg
1.2.3 100mg
1.3 Paclitaxel Drug Segment by Application
1.3.1 Paclitaxel Drug Sales Comparison by Application: (2021-2027)
1.3.2 Hospital
1.3.3 Drugs Store
1.4 Global Paclitaxel Drug Market Size Estimates and Forecasts
1.4.1 Global Paclitaxel Drug Revenue 2016-2027
1.4.2 Global Paclitaxel Drug Sales 2016-2027
1.4.3 Paclitaxel Drug Market Size by Region: 2016 Versus 2021 Versus 2027

2 Paclitaxel Drug Market Competition by Manufacturers
2.1 Global Paclitaxel Drug Sales Market Share by Manufacturers (2016-2021)
2.2 Global Paclitaxel Drug Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Paclitaxel Drug Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Paclitaxel Drug Manufacturing Sites, Area Served, Product Type
2.5 Paclitaxel Drug Market Competitive Situation and Trends
2.5.1 Paclitaxel Drug Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Paclitaxel Drug Players Market Share by Revenue
2.5.3 Global Paclitaxel Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Paclitaxel Drug Retrospective Market Scenario by Region
3.1 Global Paclitaxel Drug Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Paclitaxel Drug Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Paclitaxel Drug Market Facts & Figures by Country
3.3.1 North America Paclitaxel Drug Sales by Country
3.3.2 North America Paclitaxel Drug Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Paclitaxel Drug Market Facts & Figures by Country
3.4.1 Europe Paclitaxel Drug Sales by Country
3.4.2 Europe Paclitaxel Drug Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Paclitaxel Drug Market Facts & Figures by Region
3.5.1 Asia Pacific Paclitaxel Drug Sales by Region
3.5.2 Asia Pacific Paclitaxel Drug Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Paclitaxel Drug Market Facts & Figures by Country
3.6.1 Latin America Paclitaxel Drug Sales by Country
3.6.2 Latin America Paclitaxel Drug Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Paclitaxel Drug Market Facts & Figures by Country
3.7.1 Middle East and Africa Paclitaxel Drug Sales by Country
3.7.2 Middle East and Africa Paclitaxel Drug Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Paclitaxel Drug Historic Market Analysis by Type
4.1 Global Paclitaxel Drug Sales Market Share by Type (2016-2021)
4.2 Global Paclitaxel Drug Revenue Market Share by Type (2016-2021)
4.3 Global Paclitaxel Drug Price by Type (2016-2021)

5 Global Paclitaxel Drug Historic Market Analysis by Application
5.1 Global Paclitaxel Drug Sales Market Share by Application (2016-2021)
5.2 Global Paclitaxel Drug Revenue Market Share by Application (2016-2021)
5.3 Global Paclitaxel Drug Price by Application (2016-2021)

6 Key Companies Profiled
6.1 Luye Pharma
6.1.1 Luye Pharma Corporation Information
6.1.2 Luye Pharma Description and Business Overview
6.1.3 Luye Pharma Paclitaxel Drug Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Luye Pharma Product Portfolio
6.1.5 Luye Pharma Recent Developments/Updates
6.2 CSPC Company
6.2.1 CSPC Company Corporation Information
6.2.2 CSPC Company Description and Business Overview
6.2.3 CSPC Company Paclitaxel Drug Sales, Revenue and Gross Margin (2016-2021)
6.2.4 CSPC Company Product Portfolio
6.2.5 CSPC Company Recent Developments/Updates
6.3 Celgene
6.3.1 Celgene Corporation Information
6.3.2 Celgene Description and Business Overview
6.3.3 Celgene Paclitaxel Drug Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Celgene Product Portfolio
6.3.5 Celgene Recent Developments/Updates
6.4 Jiangsu Hengrui
6.4.1 Jiangsu Hengrui Corporation Information
6.4.2 Jiangsu Hengrui Description and Business Overview
6.4.3 Jiangsu Hengrui Paclitaxel Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Jiangsu Hengrui Product Portfolio
6.4.5 Jiangsu Hengrui Recent Developments/Updates
6.5 Bristol-Myers Squibb
6.5.1 Bristol-Myers Squibb Corporation Information
6.5.2 Bristol-Myers Squibb Description and Business Overview
6.5.3 Bristol-Myers Squibb Paclitaxel Drug Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Bristol-Myers Squibb Product Portfolio
6.5.5 Bristol-Myers Squibb Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Paclitaxel Drug Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Pfizer Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Paclitaxel Drug Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Teva Product Portfolio
6.7.5 Teva Recent Developments/Updates
6.8 Mylan
6.8.1 Mylan Corporation Information
6.8.2 Mylan Description and Business Overview
6.8.3 Mylan Paclitaxel Drug Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Mylan Product Portfolio
6.8.5 Mylan Recent Developments/Updates
6.9 Novartis
6.9.1 Novartis Corporation Information
6.9.2 Novartis Description and Business Overview
6.9.3 Novartis Paclitaxel Drug Sales, Revenue and Gross Margin (2016-2021)
6.9.4 Novartis Product Portfolio
6.9.5 Novartis Recent Developments/Updates

7 Paclitaxel Drug Manufacturing Cost Analysis
7.1 Paclitaxel Drug Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Paclitaxel Drug
7.4 Paclitaxel Drug Industrial Chain Analysis

8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Paclitaxel Drug Distributors List
8.3 Paclitaxel Drug Customers

9 Paclitaxel Drug Market Dynamics
9.1 Paclitaxel Drug Industry Trends
9.2 Paclitaxel Drug Growth Drivers
9.3 Paclitaxel Drug Market Challenges
9.4 Paclitaxel Drug Market Restraints

10 Global Market Forecast
10.1 Paclitaxel Drug Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Paclitaxel Drug by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Paclitaxel Drug by Type (2022-2027)
10.2 Paclitaxel Drug Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Paclitaxel Drug by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Paclitaxel Drug by Application (2022-2027)
10.3 Paclitaxel Drug Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Paclitaxel Drug by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Paclitaxel Drug by Region (2022-2027)

11 Research Finding and Conclusion

12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Paclitaxel Drug Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Paclitaxel Drug Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Paclitaxel Drug Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Paclitaxel Drug Covered in This Study
Table 5. Global Paclitaxel Drug Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Paclitaxel Drug Sales Share by Manufacturers (2016-2021)
Table 7. Global Paclitaxel Drug Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Paclitaxel Drug Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Paclitaxel Drug Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Paclitaxel Drug Manufacturing Sites and Area Served
Table 11. Manufacturers Paclitaxel Drug Product Type
Table 12. Global Paclitaxel Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Paclitaxel Drug by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Paclitaxel Drug as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Paclitaxel Drug Sales by Region (2016-2021) & (K Units)
Table 16. Global Paclitaxel Drug Sales Market Share by Region (2016-2021)
Table 17. Global Paclitaxel Drug Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Paclitaxel Drug Sales by Country (2016-2021) & (K Units)
Table 19. North America Paclitaxel Drug Sales Market Share by Country (2016-2021)
Table 20. North America Paclitaxel Drug Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Paclitaxel Drug Revenue Market Share by Country (2016-2021)
Table 22. Europe Paclitaxel Drug Sales by Country (2016-2021) & (K Units)
Table 23. Europe Paclitaxel Drug Sales Market Share by Country (2016-2021)
Table 24. Europe Paclitaxel Drug Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Paclitaxel Drug Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Paclitaxel Drug Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Paclitaxel Drug Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Paclitaxel Drug Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Paclitaxel Drug Revenue Market Share by Region (2016-2021)
Table 30. Latin America Paclitaxel Drug Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Paclitaxel Drug Sales Market Share by Country (2016-2021)
Table 32. Latin America Paclitaxel Drug Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Paclitaxel Drug Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Paclitaxel Drug Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Paclitaxel Drug Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Paclitaxel Drug Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Paclitaxel Drug Revenue Market Share by Country (2016-2021)
Table 38. Global Paclitaxel Drug Sales (K Units) by Type (2016-2021)
Table 39. Global Paclitaxel Drug Sales Market Share by Type (2016-2021)
Table 40. Global Paclitaxel Drug Revenue (Million US$) by Type (2016-2021)
Table 41. Global Paclitaxel Drug Revenue Share by Type (2016-2021)
Table 42. Global Paclitaxel Drug Price (US$/Unit) by Type (2016-2021)
Table 43. Global Paclitaxel Drug Sales (K Units) by Application (2016-2021)
Table 44. Global Paclitaxel Drug Sales Market Share by Application (2016-2021)
Table 45. Global Paclitaxel Drug Revenue (Million US$) by Application (2016-2021)
Table 46. Global Paclitaxel Drug Revenue Share by Application (2016-2021)
Table 47. Global Paclitaxel Drug Price (US$/Unit) by Application (2016-2021)
Table 48. Luye Pharma Corporation Information
Table 49. Luye Pharma Description and Business Overview
Table 50. Luye Pharma Paclitaxel Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Luye Pharma Paclitaxel Drug Product
Table 52. Luye Pharma Recent Developments/Updates
Table 53. CSPC Company Corporation Information
Table 54. CSPC Company Description and Business Overview
Table 55. CSPC Company Paclitaxel Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. CSPC Company Paclitaxel Drug Product
Table 57. CSPC Company Recent Developments/Updates
Table 58. Celgene Corporation Information
Table 59. Celgene Description and Business Overview
Table 60. Celgene Paclitaxel Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Celgene Paclitaxel Drug Product
Table 62. Celgene Recent Developments/Updates
Table 63. Jiangsu Hengrui Corporation Information
Table 64. Jiangsu Hengrui Description and Business Overview
Table 65. Jiangsu Hengrui Paclitaxel Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Jiangsu Hengrui Paclitaxel Drug Product
Table 67. Jiangsu Hengrui Recent Developments/Updates
Table 68. Bristol-Myers Squibb Corporation Information
Table 69. Bristol-Myers Squibb Description and Business Overview
Table 70. Bristol-Myers Squibb Paclitaxel Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Bristol-Myers Squibb Paclitaxel Drug Product
Table 72. Bristol-Myers Squibb Recent Developments/Updates
Table 73. Pfizer Corporation Information
Table 74. Pfizer Description and Business Overview
Table 75. Pfizer Paclitaxel Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Pfizer Paclitaxel Drug Product
Table 77. Pfizer Recent Developments/Updates
Table 78. Teva Corporation Information
Table 79. Teva Description and Business Overview
Table 80. Teva Paclitaxel Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Teva Paclitaxel Drug Product
Table 82. Teva Recent Developments/Updates
Table 83. Mylan Corporation Information
Table 84. Mylan Description and Business Overview
Table 85. Mylan Paclitaxel Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Mylan Paclitaxel Drug Product
Table 87. Mylan Recent Developments/Updates
Table 88. Novartis Corporation Information
Table 89. Novartis Description and Business Overview
Table 90. Novartis Paclitaxel Drug Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. Novartis Paclitaxel Drug Product
Table 92. Novartis Recent Developments/Updates
Table 93. Production Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Paclitaxel Drug Distributors List
Table 96. Paclitaxel Drug Customers List
Table 97. Paclitaxel Drug Market Trends
Table 98. Paclitaxel Drug Growth Drivers
Table 99. Paclitaxel Drug Market Restraints
Table 100. Global Paclitaxel Drug Sales Forecast by Type (2022-2027) & (K Units)
Table 101. Global Paclitaxel Drug Sales Market Share Forecast by Type (2022-2027)
Table 102. Global Paclitaxel Drug Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 103. Global Paclitaxel Drug Revenue Market Share Forecast by Type (2022-2027)
Table 104. Global Paclitaxel Drug Sales Forecast by Application (2022-2027) & (K Units)
Table 105. Global Paclitaxel Drug Sales Market Share Forecast by Application (2022-2027)
Table 106. Global Paclitaxel Drug Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 107. Global Paclitaxel Drug Revenue Market Share Forecast by Application (2022-2027)
Table 108. Global Paclitaxel Drug Sales Forecast by Region (2022-2027) & (K Units)
Table 109. Global Paclitaxel Drug Sales Market Share Forecast by Region (2022-2027)
Table 110. Global Paclitaxel Drug Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 111. Global Paclitaxel Drug Revenue Market Share Forecast by Region (2022-2027)
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Paclitaxel Drug
Figure 2. Global Paclitaxel Drug Market Share by Type in 2020 & 2027
Figure 3. 30mg Product Picture
Figure 4. 100mg Product Picture
Figure 5. Global Paclitaxel Drug Market Share by Application in 2020 & 2027
Figure 6. Hospital
Figure 7. Drugs Store
Figure 8. Global Paclitaxel Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 9. Global Paclitaxel Drug Market Size 2016-2027 (US$ Million)
Figure 10. Global Paclitaxel Drug Sales 2016-2027 (K Units)
Figure 11. Global Paclitaxel Drug Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 12. Paclitaxel Drug Sales Share by Manufacturers in 2020
Figure 13. Global Paclitaxel Drug Revenue Share by Manufacturers in 2020
Figure 14. The Global 5 and 10 Largest Paclitaxel Drug Players: Market Share by Revenue in 2020
Figure 15. Paclitaxel Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 16. Global Paclitaxel Drug Sales Market Share by Region (2016-2021)
Figure 17. Global Paclitaxel Drug Sales Market Share by Region in 2020
Figure 18. Global Paclitaxel Drug Revenue Market Share by Region (2016-2021)
Figure 19. Global Paclitaxel Drug Revenue Market Share by Region in 2020
Figure 20. U.S. Paclitaxel Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 21. Canada Paclitaxel Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 22. Germany Paclitaxel Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. France Paclitaxel Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. U.K. Paclitaxel Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. Italy Paclitaxel Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. Russia Paclitaxel Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. China Paclitaxel Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Japan Paclitaxel Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. South Korea Paclitaxel Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. India Paclitaxel Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. Australia Paclitaxel Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. Taiwan Paclitaxel Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Indonesia Paclitaxel Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Thailand Paclitaxel Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Malaysia Paclitaxel Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Philippines Paclitaxel Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Vietnam Paclitaxel Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Mexico Paclitaxel Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Brazil Paclitaxel Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Argentina Paclitaxel Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Turkey Paclitaxel Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Saudi Arabia Paclitaxel Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. UAE Paclitaxel Drug Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Sales Market Share of Paclitaxel Drug by Type (2016-2021)
Figure 45. Sales Market Share of Paclitaxel Drug by Application (2016-2021)
Figure 46. Sales Market Share of Paclitaxel Drug by Application in 2020
Figure 47. Revenue Share of Paclitaxel Drug by Application (2016-2021)
Figure 48. Revenue Share of Paclitaxel Drug by Application in 2020
Figure 49. Manufacturing Cost Structure of Paclitaxel Drug
Figure 50. Manufacturing Process Analysis of Paclitaxel Drug
Figure 51. Paclitaxel Drug Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Bottom-up and Top-down Approaches for This Report
Figure 55. Data Triangulation
Figure 56. Key Executives Interviewed